UBS AM
RXST icon

UBS AM’s RxSight RXST Stock Holding History

UBS AM’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Hold
64,510
– – ﹤0.01% 2633
2026
Q1 		$397K Hold
64,510
– – ﹤0.01% 2598
2025
Q4 		$672K Hold
64,510
– – ﹤0.01% 2259
2025
Q3 		$580K Sell
64,510
-144,153
-69% -$1.27M ﹤0.01% 2135
2025
Q2 		$2.71M Buy
208,663
+115,281
+123% +$1.73M ﹤0.01% 2006
2025
Q1 		$2.36M Buy
93,382
+8,424
+10% +$250K ﹤0.01% 1913
2024
Q4 		$2.92M Buy
84,958
+16,140
+23% +$728K ﹤0.01% 1866
2024
Q3 		$3.4M Buy
68,818
+5,266
+8% +$270K ﹤0.01% 1770
2024
Q2 		$3.82M Buy
63,552
+32,729
+106% +$1.87M ﹤0.01% 1640
2024
Q1 		$1.59M Buy
30,823
+1,900
+7% +$93.3K ﹤0.01% 1787
2023
Q4 		$1.17M Buy
28,923
+17,235
+147% +$506K ﹤0.01% 1947
2023
Q3 		$326K Buy
+11,688
New +$348K ﹤0.01% 2411

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS AM's RXST Position: Q2 2026 in Review

UBS AM held its RxSight (RXST) position steady in Q2 2026 at 64,510 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

UBS AM first reported a position in RXST in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.82M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • UBS AM held 64,510 shares of RxSight worth $311K as of Q2 2026.
  • UBS AM left its RxSight share count unchanged in Q2 2026.
  • RxSight made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2633 holding.
  • UBS AM first reported a position in RxSight in Q3 2023 and has held it in 12 quarters since.
  • UBS AM's RxSight position peaked at $3.82M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.